Khiron Life Sciences Announces Terms of Overnight Marketed Offering TORONTO, July 6, 2021 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF), is pleased...
Khiron Life Sciences Announces Closing of $14.49 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option TORONTO, Nov. 26, 2020 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron”...
After beginning the year with a 57.4% gain in Q1 and then dropping for eight consecutive months, the Global Cannabis Stock Index ended December with a big jump that enabled the...
After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing TORONTO, May 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing VANCOUVER, Feb. 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
Cannabis stocks, as measured by the Global Cannabis Stock Index, bounced back sharply from Q4 losses of 44.2%, rallying 44.2% in January to 92.33: The index, which had 43 qualifying...
Khiron Life Sciences Signs Binding LOI to Acquire 100% of NettaGrowth, Securing the First Medical THC and CBD Cannabis Licence and Cultivation Capacity in Uruguay, and Entry to the...
KCSA’s Cynthia Salarizadeh also to participate in an in-depth panel discussion focused on advertising and marketing NEW YORK, Oct. 9, 2018 /PRNewswire/ — KCSA Strategic Communications (KCSA), a fully...
Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN,...
Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 23, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ,...
Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN,...
TORONTO, Aug. 15, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQB: KHRNF), a Canadian integrated medical cannabis company with its core operations in...